BioCorRx (BICX) Payables (2010 - 2026)

BioCorRx (BICX) has 17 years of Payables data on file, last reported at $7.8 million in Q1 2026.

• Quarterly Payables fell 36.66% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (down 36.66% YoY) and the FY2025 annual result came in at $7.6 million, up 9.65% from the prior year.
• Payables advanced to $7.8 million in Q1 2026 per BICX's latest filing, from $7.6 million in the prior quarter.
• The five-year high for Payables was $13.4 million in Q2 2025, with the low at $1.6 million in Q3 2025.
• Average Payables over 5 years is $6.0 million, with a median of $5.1 million recorded in 2024.
• The widest YoY moves for Payables: up 143.81% in 2025, down 77.75% in 2025.
• BioCorRx's Payables stood at $4.2 million in 2022, then advanced by 24.98% to $5.3 million in 2023, then soared by 31.62% to $6.9 million in 2024, then increased by 9.65% to $7.6 million in 2025, then rose by 3.15% to $7.8 million in 2026.
• Business Quant data shows BICX's Payables at $7.8 million in Q1 2026, $7.6 million in Q4 2025, and $1.6 million in Q3 2025.